Fig_4.tif (444.99 kB)

The percentages of circulating Th17 and Th1 cells in patients after treatment.

Download (0 kB)
posted on 28.01.2016 by Ting Lu, Shuang Yu, Yan Liu, Congcong Yin, Jingjing Ye, Zhi Liu, Daoxin Ma, Chunyan Ji

PA means patient. (A and B) The percentages of circulating Th17 and Th1 cells before and after chemotherapy in B-NHL. (C and D) Circulating Th17 cells were significantly increased in treated B-NHL patients compared to those before treatment (P = 0.0098) while Th1 cells dramatically reduced (P = 0.0137). (E and F) Both Th17 and Th1 cells returned to normal values after treatment in B-NHL. (G) Circulating Th17 cells were dramatically elevated in relapsed patients (RL B-NHL) compared with new diagnosed patients (New B-NHL) (P<0.0001) and even normal individuals (NC) (P = 0.0015). (H) Circulating Th1 cells in relapsed patients were similar to new diagnosed patients (P = 0.7444) but still higher than normal individuals (P = 0.0014).). * P<0.05; ** P<0.01; *** P<0.001; ns, non-significant